ICAR Research Data Repository for Knowledge Management
ChatGPT (GPT-4) passed the Japanese National License Examination for Pharmacists in 2022, answering all items including those with diagrams: a descriptive study
Harvard Dataverse (Africa Rice Center, Bioversity International, CCAFS, CIAT, IFPRI, IRRI and WorldFish)
View Archive Info| Field | Value | |
| Title |
ChatGPT (GPT-4) passed the Japanese National License Examination for Pharmacists in 2022, answering all items including those with diagrams: a descriptive study
|
|
| Identifier |
https://doi.org/10.7910/DVN/NDOXMJ
|
|
| Creator |
Hiroyasu Sato
Katsuhiko Ogasawara |
|
| Publisher |
Harvard Dataverse
|
|
| Description |
The objective of this study was to assess the performance of ChatGPT (GPT-4) on all items, including those with diagrams, in the Japanese National License Examination for Pharmacists (JNLEP) and compare it with the previous GPT-3.5 model’s performance. The 107th JNLEP, conducted in 2022, with 344 items input into the GPT-4 model, was targeted for this study. Separately, 284 items, excluding those with diagrams, were entered into the GPT-3.5 model.
|
|
| Subject |
Medicine, Health and Life Sciences
|
|
| Date |
2024-03-12
|
|
| Contributor |
Cho, A Ra
|
|